Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06004973 · ClinicalTrials.gov registry record · NA
Aldena STAR Particles
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT06004973 is a NA study that has completed, run by Emory University. The registered enrollment target is 20 participants.
The verdict
NCT06004973, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The objective of this study is to find out the best method of applying STAR particles to the skin. STAR particles are very small particles with microneedles on the surface that can increase and create small punctures in the skin. The small punctures should allow for different topical medications to work more effectively. This is important to understand the potential use of STAR particles in future topical medications. This study will not use any medication with active ingredients. The study will include healthy adult participants. The first visit will be to collect medical information and assess eligibility in the study. The second visit will have the application of STAR particles on different areas of the arm, hand, and face with different pressures to determine what the most effective method of application is. The skin will be evaluated after the application, and surveys will be collected on the tolerability of the application.
Interventions
- DEVICE STAR Particles
- DEVICE Gel without STAR Particles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2024-02-07 |
| Est. Completion | 2024-12-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06004973
The ClinicalTrials.gov registry entry for NCT06004973 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which STAR Particles is the first listed.
NCT06004973 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06004973 about?
NCT06004973 is a clinical study titled "Aldena STAR Particles". The objective of this study is to find out the best method of applying STAR particles to the skin. STAR particles are very small particles with microneedles on the surface that can increase and create small punctures in the skin. The small punctures should allow for different topical medications to...
What is the current status of trial NCT06004973?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2024-02-07. Estimated completion is 2024-12-07.
What interventions are being tested in trial NCT06004973?
The interventions under investigation include: STAR Particles (DEVICE), Gel without STAR Particles (DEVICE).
Who is sponsoring clinical trial NCT06004973?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.